Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.

Look, Maxime P

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. [electronic resource] - Journal of the National Cancer Institute Jan 2002 - 116-28 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0027-8874

10.1093/jnci/94.2.116 doi


Adult
Aged
Biomarkers
Breast Neoplasms--metabolism
Female
Humans
Middle Aged
Plasminogen Activator Inhibitor 1--metabolism
Prognosis
Proportional Hazards Models
Survival Analysis
Urokinase-Type Plasminogen Activator--metabolism